MedTrace Logo

Sleep and Quality of Life in Patients With Glycogen Storage Disease on Standard Versus Modified Uncooked Cornstarch

NCT02054832 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 11

Last updated 2015-09-25

No results posted yet for this study

Summary

The aim of the present study is to determine if there is a change in quality and quantity of sleep perceived by adults and children with GSD and their parents while starting a modified UCCS (Glycosade) to prevent nocturnal hypoglycemia. The investigators also aim to evaluate if there is a change in quality of life perceived by adults and children and their parents with Glycosade.

Conditions

  • Glycogen Storage Disease Type IA
  • Glycogen Storage Disease Type IB
  • Glycogen Storage Disease Type III
  • Glycogen Storage Disease Type 0

Interventions

DIETARY_SUPPLEMENT

Glycosade

Sponsors & Collaborators

  • John Mitchell

    lead OTHER

Principal Investigators

  • John J Mitchell, MD · Montreal Children's Hospital of the MUHC

Eligibility

Min Age
2 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2014-07-31
Completion
2014-07-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02054832 on ClinicalTrials.gov